Back
Citius Pharmaceuticals Stock Price Chart
Free Stock Analysis: See What Your Stock is Really Worth
Analyze Any Stock Free
Sell
28
CTXR
Citius Pharmaceuticals
Last Price:
$3.55
Seasonality Move:
20.84%
7 Day Trial
ALL ACCESS PASS
$
7
Free Stock Analysis Report: See The True Value of Any Stock
Analyze Any Stock Free-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTXR is experiencing slight buying pressure.
Citius Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.82 | Sell |
| 20-day SMA: | 3.37 | Buy |
| 50-day SMA: | 4.89 | Sell |
| 200-day SMA: | 13.45 | Sell |
| 8-day EMA: | 3.68 | Sell |
| 20-day EMA: | 3.7 | Sell |
| 50-day EMA: | 5.13 | Sell |
| 200-day EMA: | 11.75 | Sell |
Citius Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.21 | Sell |
| Relative Strength Index (14 RSI): | 44.71 | Sell |
| Chaikin Money Flow: | 3113 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.81 - 3.85) | Buy |
| Bollinger Bands (100): | (4.17 - 12.73) | Sell |
Citius Pharmaceuticals Technical Analysis
| Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Citius Pharmaceuticals Stock
Is Citius Pharmaceuticals Stock a Buy?
-
Citius Pharmaceuticals share price is 3.56 while CTXR 8-day simple moving average is 3.82, which is a Sell signal.
-
The stock price of CTXR is 3.56 while Citius Pharmaceuticals 20-day SMA is 3.37, which makes it a Buy.
-
Citius Pharmaceuticals 50-day simple moving average is 4.89 while CTXR share price is 3.56, making it a Sell technically.
-
CTXR stock price is 3.56 and Citius Pharmaceuticals 200-day simple moving average is 13.45, creating a Sell signal.
CTXR Technical Analysis vs Fundamental Analysis
Sell
28
Citius Pharmaceuticals (CTXR)
is a Sell
Is Citius Pharmaceuticals a Buy or a Sell?
-
Citius Pharmaceuticals stock is rated a SellThe current Citius Pharmaceuticals [CTXR] share price is $3.56. The Score for CTXR is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
Citius Pharmaceuticals Stock Info
Market Cap:
27.5M
Price in USD:
3.56
Share Volume:
109K
Citius Pharmaceuticals 52-Week Range
52-Week High:
26.75
52-Week Low:
2.44
Sell
28
Citius Pharmaceuticals (CTXR)
is a Sell
Citius Pharmaceuticals Share Price Forecast
-
What is the Citius Pharmaceuticals stock price today?The Citius Pharmaceuticals stock price is 3.56 USD today.
-
Will CTXR stock go up or go down?Citius Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Citius Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Citius Pharmaceuticals is overvalued.
Is Citius Pharmaceuticals Stock a Buy?
-
Citius Pharmaceuticals share price is 3.56 while CTXR 8-day exponential moving average is 3.68, which is a Sell signal.
-
The stock price of CTXR is 3.56 while Citius Pharmaceuticals 20-day EMA is 3.70, which makes it a Sell.
-
Citius Pharmaceuticals 50-day exponential moving average is 5.13 while CTXR share price is 3.56, making it a Sell technically.
-
CTXR stock price is 3.56 and Citius Pharmaceuticals 200-day simple moving average is 11.75, creating a Sell signal.
Fundamental Analysis of Citius Pharmaceuticals
Is Citius Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.92 per share, and an increase next year of $1.21 per share.
Technical Analysis of Citius Pharmaceuticals
Should I short Citius Pharmaceuticals stock?
-
CTXR Moving Average Covergence Divergence (MACD) indicator is -0.21, suggesting Citius Pharmaceuticals is a Sell
-
Citius Pharmaceuticals Relative Strength Index (RSI) is 44.71, which suggest Citius Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Citius Pharmaceuticals is (2.81 - 3.85), which suggest Citius Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Citius Pharmaceuticals is (4.17 - 12.73), which suggest Citius Pharmaceuticals is a Sell
* Citius Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.